Why Is Cidara Therapeutics (CDTX) Stock Trending Overnight? Cidara Therapeutics Inc. (NASDAQ:CDTX) shares are trending on Friday. Benzinga · Nov 14, 2025
Cidara Therapeutics Analyst Says Lead Influenza Candidate Is 'Strategically Attractive' JP Morgan initiated coverage of Cidara Therapeutics Inc. (NASDAQ:CDTX) on Friday, citing its lead asset, CD388, for influenza, underscoring the game-changing potential of the product and multi-billion dollar potential in the U.S. alone. Benzinga · Oct 10, 2025
3 Biotech Gems to Keep on Your Radar The biotech industry's expansion seems to stem from advancements in drug development, cutting-edge technology, and substantial government backing. Given these factors, prominent biotech stocks Surrozen (SRZN), Harmony Biosciences (HRMY), and Cidara Therapeutics (CDTX) could be solid watchlist additions now. Read on…. StockNews.com · Sep 11, 2023
3 Biotech Stocks Smart Money Is After Biotech companies such as Biogen (BIIB), Cidara Therapeutics (CDTX), and Theratechnologies (THTX) with the interest of institutional investors could be worth investing in now. Continue reading…. StockNews.com · Aug 4, 2023
3 Value Stocks With Great Returns April’s robust labor market and persistently high inflation could strengthen the likelihood of interest rates remaining elevated for an extended period. So, fundamentally strong value stocks CIRCOR International (CIR), Consolidated Water (CWCO), and Cidara Therapeutics (CDTX), which have generated solid returns, could be one’s top picks now. Keep reading. StockNews.com · May 30, 2023
4 Hyper-Growth Stocks That Could Soar Coupled with the macroeconomic headwinds, the U.S. debt default crisis and consequent recessionary fears have triggered market volatility. Against this backdrop, quality growth stocks Boston Scientific (BSX), Cardinal Health (CAH), Cidara Therapeutics (CDTX), and Geospace Technologies (GEOS) could be solid buys now. Read on…. StockNews.com · May 24, 2023
4 Biotech Stocks You Don’t Want to Miss out on in 2023 The biotech industry is growing with considerable developments and government initiatives. Given the solid prospects of the industry, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Exelixis (EXEL), and Cidara Therapeutics (CDTX) could be excellent buys. Keep reading. StockNews.com · Mar 24, 2023